Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep264 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Treatment recommendations for dapagliflozin across a cardio-renal and viscero metabolic (crv-m) continuum: an expert consensus delphi study

Das Ashok , Awasthi Rajeev , Sahay Manisha , Sahoo Abhay , Hazra Prakash , Kapoor Nitin , Tiwaskar Mangesh , Bhandarkar Prashant , Sahay Rakesh , Bhattacharya Saptarshi , Saboo Banshi , Pandit Kaushik , Kishor Kamal , Marwah Tiven , Agrawal Navneet , Sharma Kamal , Khanna Umesh , Bantwal Ganapathi , Joshi Ameya , Kerkar Prafulla , Kalra Sanjay

IntroductionDapagliflozin is sub-optimally utilised in the real world. There is a lack of a comprehensive collaborative guidance for a practical approach to manage patients with cardiometabolic, renometabolic and viscerometabolic disorders. Patients across the CRV-M continuum includes patients with varied clinical profiles.MethodsTwo round Delphi study was conducted using a virtual online-digital connect appr...